gerard reach
gerard reach
Affiliation inconnue
Adresse e-mail validée de
Citée par
Citée par
Implantable glucose sensor
GS Wilson, DS Bindra, BS Hill, DR Thevenot, R Sternberg, G Reach, ...
US Patent 5,165,407, 1992
Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring
DS Bindra, Y Zhang, GS Wilson, R Sternberg, DR Thevenot, D Moatti, ...
Analytical chemistry 63 (17), 1692-1696, 1991
Study and development of multilayer needle-type enzyme-based glucose microsensors
R Sternberg, MB Barrau, L Gangiotti, DR Thévenot, DS Bindra, GS Wilson, ...
Biosensors 4 (1), 27-40, 1989
Can continuous glucose monitoring be used for the treatment of diabetes
G Reach, GS Wilson
Analytical chemistry 64 (6), 381A-386A, 1992
Progress toward the development of an implantable sensor for glucose
GS Wilson, Y Zhang, G Reach, D Moatti-Sirat, V Poitout, DR Thévenot, ...
Clinical Chemistry 38 (9), 1613-1617, 1992
A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable …
V Poitout, D Moatti-Sirat, G Reach, Y Zhang, GS Wilson, F Lemonnier, ...
Diabetologia 36 (7), 658-663, 1993
Strategies for calibrating a subcutaneous glucose sensor.
G Velho, P Froguel, DR Thevenot, G Reach
Biomedica Biochimica Acta 48 (11-12), 957-964, 1989
Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue
D Moatti-Sirat, F Capron, V Poitout, G Reach, DS Bindra, Y Zhang, ...
Diabetologia 35 (3), 224-230, 1992
Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor
D Moatti-Sirat, G Velho, G Reach
Biosensors and Bioelectronics 7 (5), 345-352, 1992
Elimination of the acetaminophen interference in an implantable glucose sensor
Y Zhang, Y Hu, GS Wilson, D Moatti-Sirat, V Poitout, G Reach
Analytical Chemistry 66 (7), 1183-1188, 1994
Which Threshold to Detect Hypoglycemia?: Value of receiver-operator curve analysis to find a compromise between sensitivity and specificity
G Reach
Diabetes Care 24 (5), 803-804, 2001
In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor.
V Poitout, D Moatti, G Velho, G Reach, R Sternberg, DR Thévenot, ...
Asaio Transactions 37 (3), M298-300, 1991
Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man
D Moatti-Sirat, V Poitout, V Thome, MN Gangnerau, Y Zhang, Y Hu, ...
Diabetologia 37 (6), 610-616, 1994
A method for evaluating in vivo the functional characteristics of glucose sensors
G Reach, P Abel, U Fischer
Biosensors 2 (4), 211-220, 1986
A user-friendly method for calibrating a subcutaneous glucose sensor-based hypoglycaemic alarm
B Aussedat, V Thome-Duret, G Reach, F Lemmonier, JC Klein, Y Hu, ...
Biosensors and Bioelectronics 12 (11), 1061-1070, 1997
In vitro and in vivo stability of electrode potentials in needle-type glucose sensors: influence of needle material
G Velho, P Froguel, R Sternberg, DR Thevenot, G Reach
Diabetes 38 (2), 164-171, 1989
Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination
V Poitout, D Moatti-Sirat, G Reach
Biosensors and Bioelectronics 7 (8), 587-592, 1992
PPAR-α–null mice are protected from high-fat diet–induced insulin resistance
M Guerre-Millo, C Rouault, P Poulain, J André, V Poitout, JM Peters, ...
Diabetes 50 (12), 2809-2814, 2001
Physiological differences between interstitial glucose and blood glucose measured in human subjects
E Kulcu, JA Tamada, G Reach, RO Potts, MJ Lesho
Diabetes care 26 (8), 2405-2409, 2003
Letters to the Editor Re
G Reach
Diabetes Technology & Therapeutics 2, 49-56, 2000
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20